[1]Bossuyt PM，Reitsma JB，Bruns DE，et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration[J]. Clin Chem，2003，49（1）:7-18.[2]王波，詹思延. 如何撰写高质量的流行病学研究论文第三讲诊断试验准确性研究的报告规范——STARD介绍[J]. 中华流行病学杂志，2006，27（10）:909-912.[3]Bossuyt PM，Reitsma JB，Bruns DE，et al. 迈向完整、准确的诊断准确性研究报告:STARD计划[J]. 中国循证医学杂志，2006，6（7）:523-528.[4]Whiting P，Rutjes AW，Reitsma JB，et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J]. BMC Med Res Methodol，2003，3:25.[5]Whiting PF，Weswood ME，Rutjes AWS，et al. QUADAS评价:一种用于诊断性研究的质量评价工具（修订版）[J]. 中国循证医学杂志，2007，7（7）: 531-536.[6]Foerch C，Niessner M，Back T，et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke[J]. Clin Chem，2012，58（1）:237-245.[7]Potocki M，Breidthardt T，Reichlin T，et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure[J]. J Intern Med，2010，267（1）:119-129.[8]DeLong ER，DeLong DM，Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach[J]. Biometrics，1988，44（3）:837-845.[9]Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve[J]. Clin Chem，2008，54（1）:17-23.[10]Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction[J]. Circulation，2007，115（7）:928-935.[11]Romero C，te Velde L，Ponsen H，et al. C-statistics versus logistic regression for assessing the performance of qualitative diagnostic tests[J]. Clin Chem Lab Med，2012，50（1）:73-76.[12]Levinson SS. Letter to the editor reply: statistical methods for assessment of added usefulness of new biomarkers[J]. Clin Chem Lab Med，2011，49（7）:1241-1242.[13]Zhao Z，Zhao Q，Warrick J，et al. Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy[J]. Clin Chem，2012，58（5）:896-905.[14]Sackett DL，Haynes RB. The architecture of diagnostic research[J]. BMJ，2002，324（7336）:539-541.[15]Levinson SS. Clinical validation of biomarkers for predicting risk[J]. Adv Clin Chem，2009，48:1-25.[16]Pencina MJ，D′Agostino RB，Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers[J]. Clin Chem Lab Med，2010，48（12）:1703-1711.[17]Pencina MJ，D′Agostino RB Sr，D′Agostino RB Jr，et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to re-classification and beyond[J]. Stat Med，2008，27（2）:157-172.
